KLRK1 and glioblastoma: It had been confirmed that both glioblastoma CSCs and paired mature glioblastoma tumour cells are weakly positive and negative for MHC-I, MHC-II, and NKG2D ligand molecules, with defective antigen-processing machinery molecules [108].